Indomethacin

Thông số

53-86-1Số CAS

200-186-5Số EC

2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetic acidTên IUPAC

C19H16ClNO4Công thức hóa học

357.8 g/molKhối lượng phân tử

indomethacin; indometacin; 53-86-1; Indomethacine; Indometacine; Indocid; Metindol; Reumacide; Indomethazine; Idomethine; Imbrilon; Mikametan; Indacin; Mobilan; Tannex; Amuno; Inteban sp; Artrinovo; Confortid; Indomecol; Indomethacinum; Metartril; Methazine; Artracin; Artrivia; Dolovin; Indomed; Indomee; Indoptic; Indoptol; Inflazon; Infrocin; Metacen; Mezolin; Sadoreum; Inacid; Lausit; Indo-rectolmin; Indo-tablinen; Indometacyna; Indometicina; Durametacin; Indo-Lemmon; Indometacinum; Indometacina; Aconip; Indocin Sr; 2-(1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)acetic acid; Osmosin; Indomet 140; Rheumacin LA; 1H-Indole-3-acetic acid, 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-; Tivorbex; Indomod; Indolar SR; 1-(p-Chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid; DTXSID9020740; NCI-C56144; FLAM; 1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetic acid; 2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetic acid; XXE1CET956; NSC-757061; 1-(p-Chlorobenzoyl)-2-methyl-5-methoxyindole-3-acetic acid; Indole-3-acetic acid, 1-(p-chlorobenzoyl)-5-methoxy-2-methyl-; CHEBI:49662; N-p-Chlorbenzoyl-5-methoxy-2-methylindole-3-acetic acid; (1-p-Chlorobenzoyl-5-methoxy-2-methylindol-3-yl)acetic acid; NSC-77541; alpha-(1-(p-Chlorobenzoyl)-2-methyl-5-methoxy-3-indolyl)acetic acid; DTXCID50740; 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico; 1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3-indolylacetic acid; Kwas 1-(p-chlorobenzoilo)-2-metylo-5-metoksy-3-indolilooctowy; [1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]acetic acid; 2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]acetic acid; {1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid; 1-(p-Chlorbenzoyl)-5-methoxy-2-methylindol-3-essigsaeure; (1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYL-1H-INDOL-3-YL)ACETIC ACID; NSC77541; Indoderm; Indoflex; Indolar; Ledmecin; Rimacid; Pardelprin mr; Artracin sr; Indocid ret; 2-(1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl)acetic acid; Indomethacin ER; Maximet sr; Indo-paed; Indocid-r; Slo-indo; (1-((4-chlorophenyl)carbonyl)-5-methoxy-2-methyl-1H-indol-3-yl)acetic acid; Berlind 75 ret; Indotard mr 75; Indomax-25; Indomax-75 sr; Flexin-25 continus; Flexin-50 continus; Flexin-75 continus; RefChem:5905; Indomethacin Extended-release; C01EB03; M01AB01; M02AA23; S01BC01; 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1-H-indole-3-acetic acid; 200-186-5; Indocin; Catlep; Dolcidium; Elmetacin; Indomethine; Indorektal; Indoxen; Vonum; Indo-phlogont; Chibro-amuno; 1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-3-indoleacetic acid; MFCD00057095; CCRIS 3502; HSDB 3101; Indometacin [INN]; CHEMBL6; IMN; MLS000069402; Indomethacin (Indocid, Indocin); 1-(p-Chlorobenzoyl)-2-methoxy-3-methyl-1H-indole-3-acetic Acid; 2-{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1h-indol-3-yl}acetic acid; s1723; CAS-53-86-1; NCGC00015562-18; Indmethacine; Indomethancin; Arthrexin; Bonidin; Bonidon; Indameth; Miametan; SMR000058195; Indomo; Flexin continus; Hicin; Chrono-indicid; Chrono-indocid; Indometacyna [Polish]; 2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-indol-3-yl]acetic acid; Bonidon Gel; Indometicina [Spanish]; Dolcidium PL; Indo-Spray; Indometacine [INN-French]; Indometacinum [INN-Latin]; Indometacina [INN-Spanish]; 1-(4-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid; Indonol; Innamit; Inteban; 2-{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methylindol-3-yl}acetic acid; Indocin (TN); Aconip (TN); Indomethacin (USP); Indocid (pharmaceutical); SR-01000000014; EINECS 200-186-5; Indomethacin & MAP-30; Indomethacin [USAN:USP]; UNII-XXE1CET956; BRN 0497341; Indocollyre; 1-(p-Chlorobenzoyl)-5-methoxy-2-methyl-Indole-3-acetic acid; Artracin;; Imbrilon;; Indocid;; Indocin;; Indomed;; Indometacin CRS; 2-{1-((4-chlorophenyl)carbonyl)-5-methoxy-2-methylindol-3-yl}acetic acid; Flexin;; Indocin-SR; 4kyk; Indochron E-R; Prestwick_597; Indomethacin (GMP); USAN; Opera_ID_56; Spectrum_000919; Tocris-1708; 1z9h; Indomethacin (Standard); 1-(p-Chlorbenzoyl)-5-methoxy-2-methylindol-3-essigsaeure [German]; 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish]; Prestwick0_000272; Prestwick1_000272; Prestwick2_000272; Prestwick3_000272; Spectrum2_000970; Spectrum3_000468; Spectrum4_000018; Spectrum5_000868; INDOMETACIN [JAN]; INDOMETHACIN [MI]; Lopac-I-7378; Kwas 1-(p-chlorobenzoilo)-2-metylo-5-metoksy-3-indolilooctowy [Polish]; Indometacin (Indomethacin); Epitope ID:613433; MolMap_000032; UPCMLD-DP023; EC 200-186-5; I 7378; Indometacin (JP18/INN); INDOMETHACIN [HSDB]; INDOMETHACIN [USAN]; SCHEMBL9300; INDOMETACIN [MART.]; INDOMETHACIN [VANDF]; Lopac0_000692; Oprea1_686105; BSPBio_000144; BSPBio_001149; BSPBio_002176; INDOMETACIN [WHO-DD]; INDOMETACIN [WHO-IP]; KBioGR_000395; KBioGR_000489; KBioSS_000489; KBioSS_001399; 5-22-05-00239 (Beilstein Handbook Reference); MLS001074194; MLS006011845; BIDD:GT0132; DivK1c_000271; INDOMETHACIN [USP-RS]; SPECTRUM1500350; SPBio_000979; SPBio_002363; BPBio1_000160; GTPL1909; orb1224753; orb1310593; Indometacin impurity mixture CRS; Indomethacin, >=99% (TLC); SCHEMBL11563010; SCHEMBL29353712; UPCMLD-DP023:001; BDBM17638; CGIGDMFJXJATDK-UHFFFAOYSA-; HMS500N13; KBio1_000271; KBio2_000489; KBio2_001399; KBio2_003057; KBio2_003967; KBio2_005625; KBio2_006535; KBio3_000897; KBio3_000898; KBio3_001396; MSK7168; NINDS_000271; Bio2_000405; Bio2_000885; HMS1362I11; HMS1568H06; HMS1792I11; HMS1920F21; HMS1990I11; HMS2089N19; HMS2091N09; HMS2095H06; HMS2231J10; HMS3262K05; HMS3268A14; HMS3374F07; HMS3403I11; HMS3414N13; HMS3430L03; HMS3649K17; HMS3655O04; HMS3678N11; HMS3712H06; HMS3747K21; HMS3884E08; HMS5079F18; INDOMETACIN [EP MONOGRAPH]; Indomethacin - Bio-X trade mark; INDOMETHACIN [ORANGE BOOK]; Pharmakon1600-01500350; MDA37708; INDOMETHACIN [USP MONOGRAPH]; Tox21_113109; Tox21_201791; Tox21_300266; Tox21_500692; AC-532; CCG-40186; EBC-04405; HB4422; HY-14397G; HY-14397R; INDOMETACINUM [WHO-IP LATIN]; NSC757061; SBB057417; STL257874; AKOS000592893; Indometacin; Acemetacin EP Impurity B; Tox21_113109_1; AT13679; DB00328; FI24585; Indometacin 1.0 mg/ml in Acetonitrile; KS-5255; LP00692; NSC 757061; SDCCGSBI-0050670.P005; IDI1_000271; IDI1_002160; NCGC00015562-01; NCGC00015562-02; NCGC00015562-03; NCGC00015562-04; NCGC00015562-05; NCGC00015562-06; NCGC00015562-07; NCGC00015562-08; NCGC00015562-09; NCGC00015562-10; NCGC00015562-11; NCGC00015562-12; NCGC00015562-13; NCGC00015562-14; NCGC00015562-15; NCGC00015562-16; NCGC00015562-17; NCGC00015562-19; NCGC00015562-20; NCGC00015562-21; NCGC00015562-22; NCGC00015562-24; NCGC00015562-25; NCGC00015562-30; NCGC00015562-40; NCGC00024135-02; NCGC00024135-04; NCGC00024135-05; NCGC00024135-06; NCGC00024135-07; NCGC00024135-08; NCGC00024135-09; NCGC00024135-10; NCGC00024135-11; NCGC00024135-12; NCGC00024135-13; NCGC00024135-14; NCGC00024135-15; NCGC00254075-01; NCGC00259340-01; NCGC00261377-01; BI166166; BP-30207; HY-14397; NCI60_041708; O-Desmethyl-des-4-chlorobenzoylacemetacin; SBI-0050670.P004; ACEMETACIN IMPURITY B [EP IMPURITY]; DB-052413; AB00052022; EU-0100692; I0655; I5315; NS00000217; ST50320042; SW196768-5; EN300-16807; Indomethacin, meets USP testing specifications; BIM-0050670.0001; C01926; D00141; S00108; AB00052022-20; AB00052022-21; AB00052022_23; AB00052022_24; F358171; L000959; Q409231; SR-01000000014-2; SR-01000000014-4; SR-01000000014-6; 1-(4-Chlorobenzoyl)-5-methoxy-2-met hyl-1H-indole; BRD-K57222227-001-06-1; BRD-K57222227-001-18-6; BRD-K57222227-001-27-7; BRD-K57222227-001-28-5; BRD-K57222227-001-29-3; BRD-K57222227-001-30-1; SR-01000000014-10; SR-01000000014-16; Z56784896; 1-p-chlorobenzoyl-2-methyl-5-methoxyindol-3-acetic acid; 1-(p-chlorobenzoyl)-2-methyl-5-methoxy-3-indoleacetic acid; 1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3-indoleacetic acid; 1-(p-Chlorobenzoyl)-5-methoxy-2-methylindol-3-acetic acid; 1-(p-chlorobenzyl)-5-methoxy-2-methylindole-3-acetic acid; 1-(4-chloro-benzoyl)-5-methoxy-2-methyl-3-indolyl-acetic acid; 1-(4-Chlorobenzoyl)-2-methyl-5-methoxyindole-3-acetic acid; 1-(p-Chlorobenzoyl)-2-methyl-5-methoxy-3-indole-acetic acid; 1-(p-chlorobenzoyl)-2-methyl-5-methoxy-3-indolylacetic acid; 1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3-indol acetic acid; Indomethacin, European Pharmacopoeia (EP) Reference Standard; N-(p-Chlorobenzoyl)-2-methyl-5-methoxy-3-indolylacetic acid; Indomethacin, United States Pharmacopeia (USP) Reference Standard; .alpha.-(1-(p-Chlorobenzoyl)-2-methyl-5-methoxy-3-indolyl)acetic acid; [1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]acetic acid #; 1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetic acid & MAP-30; 1H-Indole-3-acetic acid, 1-(4-chlorobenzoyl)-5-methoxy-2-methyl- (9CI); 2-{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2 methylindol-3-yl}acetic acid; 2-{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2methylindol-3-yl}acetic acid; Indole-3-acetic acid, 1-(p-chlorobenzoyl)-5-methoxy-2-methyl- (8CI); Indomethacin, Pharmaceutical Secondary Standard; Certified Reference Material; InChI=1/C19H16ClNO4/c1-11-15(10-18(22)23)16-9-14(25-2)7-8-17(16)21(11)19(24)12-3-5-13(20)6-4-12/h3-9H,10H2,1-2H3,(H,22,23)Tên gọi khác